From Mike Lee U.S. Senator of Utah July 13, 2023, WASHINGTON – Sens. Mike Lee (R-UT), Ben Ray Luján (D-NM), Mike Braun (R-IN), and J.D. Vance (R-OH) introduced the Biosimilar Red Tape Elimination Act to increase competition within the biological drug market and increase access to low-cost prescription drugs. <Read Full Article>… Continue reading
From BioBuzz by Workforce Genetics By Steven Surdez 12AUG2022 A key recent hire for BioFactura was biosimilars and scientific affairs expert Rodeina Challand, who joined the team as its new VP of Scientific Affairs in late 2021. We caught up with Challand to discuss her background, the biosimilars market landscape, and why she’s excited about what’s next … Continue reading
From Generics Bulletin/Informa Pharma Intelligence By Dean Rudge 14SEP2021 BioFactura, which is already using its ‘StableFast’ technology platform to develop its biosimilar ustekinumab candidate, has allied with fellow US-based biotech Rani Therapeutics to see if the biologic can be formulated into Rani’s proprietary ‘robotic’ pill. <Read Full Article>… Continue reading
From U.S. Department of Health and Human Services By DHHS 26SEP2019 The U.S. Department of Health and Human Services will sponsor development of a novel therapeutic to treat smallpox infections. The variola virus, which causes smallpox was eradicated but remains a potential health security threat… Read Full Artic… Continue reading
From ClinicalTrialsArena.com By Elizabeth Williams 15AUG2018 CTA’s Elizabeth Williams catches up with Jeffrey Hausfeld, CMO, BioFactura, on the complexities of carrying out early phase studies. <Read Full Article>… Continue reading
Washington D.C, 29th April 2018 Dr. Jeffrey Hausfeld M.D., M.B.A., F.A.C.S, chairman and co-founder of the global biomedical and healthcare innovation network, Society of Physician Entrepreneurs (www.sopenet.org), partners with and attends the The 15th Annual World Health Care Congress in Washington D.C. from April 29th – May 2nd, 2018. He will be co–moderating the inaugural … Continue reading
Frederick County’s commercial real estate industry was honored this evening at the inaugural Frederick Real Estate Dealmakers (FRED) Awards. Hosted by the Frederick County Office of Economic Development, the FRED Awards recognized the most successful commercial real estate transactions and projects of 2016 – and the people who made them happen. The impacts on Frederick County’s economy … Continue reading
Biologic drugs offer highly effective medical treatments, but come with a hefty price tag. Creating biosimilar versions may change that… Continue reading
Getting biosimilars right at the manufacturing stage is vitally important, as there must be no clinically meaningful differences between the follow-on biologic and its reference product. Even small changes to cell lines can lead to major changes in how a biologic behaves, including its safety, efficacy and ability to trigger immune reactions. Creating an alliance with a biomanufacturing company… Continue reading
Momenta Pharmaceuticals has partnered on the development of an undisclosed biosimilar using BioFactura’s StableFast biomanufacturing platform… Continue reading